Twist Bioscience (TWST) Stock Forecast & Price Target $159.85 +14.60 (+10.05%) Closing price 10/27/2026 04:00 PM EasternExtended Trading$163.28 +3.43 (+2.15%) As of 07:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Twist Bioscience - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating HoldBased on 13 Analyst RatingsSell2Hold3Buy8 Based on 13 Wall Street analysts who have issued ratings for Twist Bioscience in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 2 have given a sell rating, 3 have given a hold rating, and 8 have given a buy rating for TWST. Consensus Price Target $143.67-10.12% Downside According to the 13 analysts' twelve-month price targets for Twist Bioscience, the average price target is $143.67. The highest price target for TWST is $215.00, while the lowest price target for TWST is $41.00. The average price target represents a forecasted downside of -10.12% from the current price of $159.85. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for TWST and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Twist Bioscience and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TWST Analyst Ratings Over TimeTypeCurrent Forecast10/28/25 to 10/28/261 Month Ago9/28/25 to 9/28/263 Months Ago7/30/25 to 7/30/261 Year Ago10/28/24 to 10/28/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy8 Buy rating(s)8 Buy rating(s)8 Buy rating(s)8 Buy rating(s)Hold3 Hold rating(s)2 Hold rating(s)1 Hold rating(s)0 Hold rating(s)Sell2 Sell rating(s)2 Sell rating(s)1 Sell rating(s)2 Sell rating(s)Consensus Price Target$143.67$103.00$90.30$48.56Forecasted Upside-10.12% Downside-42.65% Downside-1.13% Downside44.64% UpsideConsensus RatingHoldModerate BuyModerate BuyModerate Buy TWST Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History TWST Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Twist Bioscience Stock vs. The CompetitionTypeTwist BioscienceHealthcare CompaniesBroader MarketConsensus Rating Score 2.46 2.32 2.53Consensus RatingHoldHoldModerate BuyPredicted Upside-10.12% Downside108.32% Upside16.43% UpsideNews Sentiment RatingPositive NewsSee Recent TWST NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings Most Recent from Each Brokerage All Show All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action 10/28/2024 - 10/28/2026 Report Date Report Date From Report Date To 1M3M6MYTD1Y2Y3Y5Y More filters Fewer filters Done 0 Results Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/13/2026 TD Cowen3 of 5 starsBrendan SmithNot RatedBoost TargetBuy$115.00 ➝ $190.00+28.12%10/12/2026 Canaccord Genuity Group3 of 5 starsKyle Mikson4 of 5 starsBoost TargetBuy$120.00 ➝ $205.00+28.30%10/8/2026 Jefferies Financial Group3 of 5 starsMatthew StantonNot RatedInitiated CoverageHold$150.00-3.63%10/7/2026 BarclaysSubscribe to MarketBeat All Access to unlock brokerage rankingsLuke SergottSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetOverweight$112.00 ➝ $215.00+28.77%10/1/2026 GuggenheimSubscribe to MarketBeat All Access to unlock brokerage rankingsSubbu NambiSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetBuy$107.00 ➝ $212.00+7.56%9/29/2026 Leerink PartnersSubscribe to MarketBeat All Access to unlock brokerage rankingsPuneet SoudaSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetOutperform$160.00 ➝ $190.00+4.43%9/21/2026 Weiss RatingsSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingSell (D-)9/18/2026 BWS FinancialSubscribe to MarketBeat All Access to unlock brokerage rankingsHamed KhorsandSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingSell$45.00-71.75%9/9/2026 UBS GroupSubscribe to MarketBeat All Access to unlock brokerage rankingsDoug SchenkelSubscribe to MarketBeat All Access to unlock analyst rankingsInitiated CoverageNeutral$144.00+12.45%8/5/2026 Piper SandlerSubscribe to MarketBeat All Access to unlock brokerage rankingsDavid WestenbergSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetOverweight$85.00 ➝ $115.00+15.65% Get the Latest News and Ratings for TWST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. 8/4/2026 Robert W. BairdSubscribe to MarketBeat All Access to unlock brokerage rankingsCatherine Ramsey SchulteSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetOutperform$113.00 ➝ $115.00+13.79%7/6/2026 EvercoreSubscribe to MarketBeat All Access to unlock brokerage rankings DowngradeOutperform ➝ In-Line$102.00+2.78%11/3/2025 StephensSubscribe to MarketBeat All Access to unlock brokerage rankingsSteven EtochSubscribe to MarketBeat All Access to unlock analyst rankingsInitiated CoverageOverweight$41.00+29.87%5/6/2025 The Goldman Sachs GroupSubscribe to MarketBeat All Access to unlock brokerage rankingsMatthew SykesSubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetBuy$55.00 ➝ $48.00+40.72%5/6/2025 JPMorgan Chase & Co.Subscribe to MarketBeat All Access to unlock brokerage rankingsRachel VatnsdalSubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetUnderweight$40.00 ➝ $33.00-8.15%2/4/2025 ScotiabankSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingOutperform12/13/2024 Wolfe ResearchSubscribe to MarketBeat All Access to unlock brokerage rankingsDoug SchenkelSubscribe to MarketBeat All Access to unlock analyst rankingsInitiated CoverageOutperform$60.00+26.61%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 07:22 AM ET. TWST Forecast - Frequently Asked Questions What is Twist Bioscience's forecast for 2026? According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Twist Bioscience is $143.67, with a high forecast of $215.00 and a low forecast of $41.00. Should I buy or sell Twist Bioscience stock right now? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. There are currently 2 sell ratings, 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TWST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TWST, but not buy additional shares or sell existing shares. Does Twist Bioscience's stock price have much downside? According to analysts, Twist Bioscience's stock has a predicted downside of -10.12% based on their 12-month stock forecasts. What analysts cover Twist Bioscience? Twist Bioscience has been rated by research analysts at Barclays, BWS Financial, Canaccord Genuity Group, Guggenheim, Jefferies Financial Group, Leerink Partners, Piper Sandler, Robert W. Baird, TD Cowen, UBS Group, and Weiss Ratings in the past 90 days. Do Wall Street analysts like Twist Bioscience more than its competitors? Analysts like Twist Bioscience more than other "healthcare" companies. The consensus rating score for Twist Bioscience is 2.46 while the average consensus rating score for "healthcare" companies is 2.32. Learn more on how TWST compares to other companies. Stock Forecasts and Research Tools Related Companies TXG Stock Forecast DNA Stock Forecast MTD Stock Forecast MEDP Stock Forecast RVTY Stock Forecast CRL Stock Forecast ICLR Stock Forecast TECH Stock Forecast AVTR Stock Forecast RGEN Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Twist Bioscience RecommendationsTD CowenCanaccord Genuity GroupJefferies Financial GroupBarclaysGuggenheimLeerink PartnersWeiss RatingsBWS FinancialUBS GroupPiper SandlerRobert W. BairdEvercoreStephens MarketBeat monitors more than a dozen sources for Twist Bioscience analyst ratings, with the most recent rating issued on 10/13/2026. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredYesterday's deadline changed everythingIn June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times th...Behind the Markets | SponsoredNvidia's $550 Trillion ProblemDo not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Al...Decentralized Masters | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
